Sabby Management »

Checkpoint Therapeutics shares owned by Sabby Management

Quarter-by-quarter ownership of Checkpoint Therapeutics (CKPT) shares owned by Sabby Management from 13F filings

Historical chart of Sabby Management investment in Checkpoint Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Checkpoint Therapeutics held by Sabby Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Checkpoint Therapeutics by Sabby Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $349k 205k 1.70

More positions owned by Sabby Management

Ishares Tr Etf Put Option
SPDR S&P 500 Etf Put Option
Ishares Tr Etf (IWM)
SPDR S&P 500 Etf (SPY)
Apricus Biosciences
Tuanche Ads
Recon Technology Cl A (RCON)
Biora Therapeutics Ord (BIOR)
Akari Therapeutics Adr
Tonix Pharmaceuticals Hldg (TNXP)
Reviva Pharmaceutcls Hldgs I Put Option
Reviva Pharmaceutcls Hldgs I Call Option
Nisun Intl Ent Dvpmt Gp SHS (NISN)
Integrity Applications (GCTK)
Dogness Intl Corp Cl A

View all positions for Sabby Management

Top funds holding Checkpoint Therapeutics

Armistice Capital
Vanguard Group
Susquehanna International
Geode Capital Management
Citadel Advisors
BlackRock
Advisor Group Holdings
Pvg Asset Management
D. E. Shaw & Co
Legacy Wealth Asset Management
Envestnet Asset Management
Millennium Management
Royal Bank of Canada
Park Avenue Securities
Rsm Us Wealth Management

View all funds holding Checkpoint Therapeutics